🇺🇸 Nivolumab and/or Ipilimumab in United States

Nivolumab and/or Ipilimumab (nivolumab-and-or-ipilimumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nivolumab and/or Ipilimumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nivolumab and/or Ipilimumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nivolumab and/or Ipilimumab in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.